Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 79
Filtrar
1.
Ren Fail ; 42(1): 1015-1021, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-32985319

RESUMO

BACKGROUND: Glycosuria is one of the manifestations of acute tubulointerstitial nephritis (ATIN), but may also be observed in other renal diseases. In this study, we investigated the value of non-diabetic glycosuria as a diagnostic clue for ATIN. METHODS: We retrospectively reviewed the medical records of adult patients who underwent a kidney biopsy as an evaluation for serum creatinine > 1.4 mg/dL. Patients with proteinuria in the nephrotic range, diabetes mellitus, or transplanted kidney were excluded. The laboratory abnormalities suggestive of tubular injury were compared between 28 patients (14 men and 14 women, mean age 48.5 ± 14.1 years) with ATIN and 116 patients (76 men and 40 women, mean age 53.1 ± 15.0 years) with other diagnoses. RESULTS: In ATIN, glycosuria (≥ 1+ on dipstick; 68%) was more frequent than hypophosphatemia (18%), hypouricemia (18%), hypokalemia (18%), and tubular proteinuria (40%). In other diagnoses, glycosuria (≥ 1+) was detected in 7 (6%) patients; 6 of them had the histological diagnosis of antineutrophil cytoplasmic antibody-associated glomerulonephritis. The presence of glycosuria (≥ 1+) had 68% sensitivity and 94% specificity for ATIN, with the positive likelihood ratio of 11.24 and the negative likelihood ratio of 0.34. Pyuria and low total CO2 were equally and more sensitive (68% and 71%, respectively) than glycosuria (≥ 1+), but had no diagnostic value due to low specificities (58% and 60%, respectively). CONCLUSION: In non-diabetic, non-nephrotic patients undergoing a kidney biopsy for azotemia, 1+ or higher glycosuria, if present, was a good predictor of the diagnosis of ATIN.


Assuntos
Azotemia/etiologia , Glicosúria/etiologia , Rim/patologia , Nefrite Intersticial/diagnóstico , Nefrite Intersticial/urina , Adulto , Idoso , Biópsia , Creatinina/sangue , Feminino , Humanos , Hipopotassemia/etiologia , Masculino , Pessoa de Meia-Idade , Nefrite Intersticial/sangue , Nefrite Intersticial/patologia , Proteinúria/etiologia , Estudos Retrospectivos , Sensibilidade e Especificidade
2.
Nephron ; 144(8): 400-412, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32629454

RESUMO

INTRODUCTION: Alström syndrome is a rare recessive genetic disease caused by mutations in ALMS1, which encodes a protein that is related to cilia function and intracellular endosome trafficking. The syndrome has been linked to impaired glucose metabolism and CKD. Polymorphisms in Alms1 have likewise been linked to CKD, but little is known about the modification of the phenotype by environmental factors. METHODS: To gain further insights, the fat aussie (foz) mouse strain, a genetic murine model of Alström syndrome, was exposed to a normal chow (NC) or to a Western diet (WD, 20% fat, 34% sucrose by weight, and 0.2% cholesterol) and renal outcomes were measured. RESULTS: Body weight and albuminuria were higher in foz than in wild-type (WT) mice on both diets but WD significantly increased the difference. Measurement of plasma creatinine and cystatin C indicated that glomerular filtration rate was preserved in foz versus WT independent of diet. Renal markers of injury, inflammation, and fibrosis were similar in both genotypes on NC but significantly greater in foz than in WT mice on WD. A glucose tolerance test performed in foz and WT mice on WD revealed similar basal blood glucose levels and subsequent blood glucose profiles. CONCLUSIONS: WD sensitizes a murine model of Alström syndrome to kidney injury, inflammation, and fibrosis, an effect that may not be solely due to effects on glucose metabolism. Polymorphisms in Alms1 may induce CKD in part by modulating the deleterious effects of high dietary fat and sucrose on kidney outcome.


Assuntos
Síndrome de Alstrom/complicações , Dieta Ocidental/efeitos adversos , Rim/metabolismo , Rim/patologia , Nefrite/etiologia , Animais , Glicemia/análise , Proteínas de Ciclo Celular/genética , Cílios , Modelos Animais de Doenças , Fibrose , Taxa de Filtração Glomerular , Glicosúria/etiologia , Rim/fisiopatologia , Túbulos Renais/ultraestrutura , Leptina/sangue , Masculino , Camundongos , Nefrite/fisiopatologia , Obesidade/etiologia , Tamanho do Órgão , Renina/genética , Renina/metabolismo
3.
Pediatr Rheumatol Online J ; 18(1): 39, 2020 May 24.
Artigo em Inglês | MEDLINE | ID: mdl-32448292

RESUMO

BACKGROUND: Sjögren syndrome (SS) is a rare disease in pediatrics, and little attention has been paid to the clinical feature in these patients. To date, there are few cases concern about neurological and nephrological disorders in childhood Sjögren syndrome. We describe a case of Sjögren syndrome in a 12-year-old girl who developed neurological disorders and interstitial nephritis and review the literature currently available on this topic. CASE PRESENTATION: A 12-year-old girl was admitted to our hospital for arthritis and glucosuria. She was required to do labial gland and renal biopsy, because the positive for anti-nuclear antibody and anti-Sjögren syndrome B (anti-SSB) antibody. Then the biopsy was performed revealing the lymphocytic infiltrate in the small area and renal tubular interstitial damage,thus the diagnosis of Sjögren syndrome with tubular interstitial damage was made. Three months later, she presented again with headache, fever, nausea, vomiting and was recovered without drug therapy. Based on the patient's medical history, laboratory and imaging examination, and treatment, we speculate that the disorders of the nervous system were caused by the Sjögren syndrome. The girl has stable renal function and no residual nervous system damage in the next 1.5 years, but she underwent low dose prednisone therapy because of persistent renal glucosuria. CONCLUSIONS: Nephrological disorders and neurological involvement are rare manifestations of Sjögren syndrome in children, and rarely presented as the initial symptoms. It should be suspected in children presenting with unexplained renal diseases, neurological abnormalities, or unexplained fever. Although there is no guidelines on the diagnosis and treatment of children Sjögren syndrome are currently available, early recognition and the appropriate treatment of renal damage and neurologic involvement would improve prognosis and prevent complications.


Assuntos
Artrite/fisiopatologia , Meningite Asséptica/fisiopatologia , Nefrite Intersticial/fisiopatologia , Síndrome de Sjogren/fisiopatologia , Anticorpos Anticitoplasma de Neutrófilos/imunologia , Anticorpos Antinucleares/imunologia , Artrite/etiologia , Criança , Feminino , Glicosúria/etiologia , Humanos , Meningite Asséptica/etiologia , Nefrite Intersticial/etiologia , Nefrite Intersticial/patologia , Nefrite Intersticial/urina , Glândulas Salivares Menores/patologia , Síndrome de Sjogren/complicações , Síndrome de Sjogren/imunologia , Síndrome de Sjogren/patologia
4.
Acta Diabetol ; 56(1): 45-53, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30159749

RESUMO

AIMS: Previous studies indicated that urinary glucose (UG) had a limited efficacy in diabetes screening. This study was designed to have a re-evaluation of its efficacy, taking into consideration the collection method of urine and the measurement approach for UG among Chinese adults. METHODS: This cross-sectional study enrolled a total of 7689 participants without known diabetes, who were fasted and asked to empty bladders before a 75 g glucose loading. Urine was collected 2 h post glucose loading, and UG was measured using quantitative and qualitative approaches. The efficacy of UG in detecting diabetes was assessed by the receiver operating characteristic (ROC) curve. RESULTS: The area under the ROC curve was 0.89 for quantitative UG and 0.87 for qualitative UG. Quantitative UG was positively correlated with fasting plasma glucose (FPG) and 2 h plasma glucose (2 h PG) (r = 0.55 and 0.56, respectively, both P < 0.001). Quantitative UG displayed a sensitivity of 82.9% and a specificity of 84.7% in detecting diabetes at the corresponding optimal cutoff of 130 mg. Qualitative UG exhibited a sensitivity of 80.2% and a specificity of 85.6% at the optimal cutoff of glycosuria + 1. In addition, the sensitivity of both quantitative and qualitative UG was significantly higher than that of HbA1c (≥ 6.5%) (P < 0.001) and had a comparable sensitivity to 2 h PG (≥ 11.1 mmol/L) (P = 0.493). CONCLUSIONS: UG, either quantitatively or qualitatively measured at 2 h post glucose loading, was effective in diabetes screening. This indicates that UG is a feasible approach for diabetes screening.


Assuntos
Diabetes Mellitus/diagnóstico , Diabetes Mellitus/urina , Glicosúria/urina , Programas de Rastreamento/métodos , Adolescente , Adulto , Idoso , Glicemia/análise , Estudos Transversais , Diabetes Mellitus/sangue , Jejum/sangue , Jejum/urina , Estudos de Viabilidade , Feminino , Glucose/análise , Teste de Tolerância a Glucose , Glicosúria/diagnóstico , Glicosúria/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Sensibilidade e Especificidade , Urinálise , Adulto Jovem
5.
Cardiovasc Diabetol ; 17(1): 108, 2018 07 30.
Artigo em Inglês | MEDLINE | ID: mdl-30060748

RESUMO

BACKGROUND: Arterial stiffness is emerging as an independent risk factor for the development of chronic kidney disease. The sodium glucose co-transporter 2 (SGLT2) inhibitors, which lower serum glucose by inhibiting SGLT2-mediated glucose reabsorption in renal proximal tubules, have shown promise in reducing arterial stiffness and the risk of cardiovascular and kidney disease in individuals with type 2 diabetes mellitus. Since hyperglycemia contributes to arterial stiffness, we hypothesized that the SGLT2 inhibitor empagliflozin (EMPA) would improve endothelial function, reduce aortic stiffness, and attenuate kidney disease by lowering hyperglycemia in type 2 diabetic female mice (db/db). MATERIALS/METHODS: Ten-week-old female wild-type control (C57BLKS/J) and db/db (BKS.Cg-Dock7m+/+Leprdb/J) mice were divided into three groups: lean untreated controls (CkC, n = 17), untreated db/db (DbC, n = 19) and EMPA-treated db/db mice (DbE, n = 19). EMPA was mixed with normal mouse chow at a concentration to deliver 10 mg kg-1 day-1, and fed for 5 weeks, initiated at 11 weeks of age. RESULTS: Compared to CkC, DbC showed increased glucose levels, blood pressure, aortic and endothelial cell stiffness, and impaired endothelium-dependent vasorelaxation. Furthermore, DbC exhibited impaired activation of endothelial nitric oxide synthase, increased renal resistivity and pulsatility indexes, enhanced renal expression of advanced glycation end products, and periarterial and tubulointerstitial fibrosis. EMPA promoted glycosuria and blunted these vascular and renal impairments, without affecting increases in blood pressure. In addition, expression of "reversion inducing cysteine rich protein with Kazal motifs" (RECK), an anti-fibrotic mediator, was significantly suppressed in DbC kidneys and partially restored by EMPA. Confirming the in vivo data, EMPA reversed high glucose-induced RECK suppression in human proximal tubule cells. CONCLUSIONS: Empagliflozin ameliorates kidney injury in type 2 diabetic female mice by promoting glycosuria, and possibly by reducing systemic and renal artery stiffness, and reversing RECK suppression.


Assuntos
Compostos Benzidrílicos/farmacologia , Glicemia/efeitos dos fármacos , Diabetes Mellitus Tipo 2/tratamento farmacológico , Angiopatias Diabéticas/prevenção & controle , Nefropatias Diabéticas/prevenção & controle , Glucosídeos/farmacologia , Rim/irrigação sanguínea , Rim/efeitos dos fármacos , Circulação Renal/efeitos dos fármacos , Inibidores do Transportador 2 de Sódio-Glicose/farmacologia , Transportador 2 de Glucose-Sódio/metabolismo , Rigidez Vascular/efeitos dos fármacos , Albuminúria/etiologia , Albuminúria/prevenção & controle , Animais , Glicemia/metabolismo , Linhagem Celular , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/genética , Angiopatias Diabéticas/etiologia , Angiopatias Diabéticas/fisiopatologia , Nefropatias Diabéticas/etiologia , Nefropatias Diabéticas/patologia , Nefropatias Diabéticas/fisiopatologia , Modelos Animais de Doenças , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/metabolismo , Endotélio Vascular/fisiopatologia , Feminino , Proteínas Ligadas por GPI/metabolismo , Glicosúria/etiologia , Glicosúria/prevenção & controle , Humanos , Rim/metabolismo , Rim/patologia , Camundongos Endogâmicos C57BL , Camundongos Mutantes , Fluxo Pulsátil/efeitos dos fármacos , Resistência Vascular/efeitos dos fármacos , Vasodilatação/efeitos dos fármacos
6.
BMJ Case Rep ; 20182018 May 07.
Artigo em Inglês | MEDLINE | ID: mdl-29735496

RESUMO

A 64-year-old woman had fragility fractures which caused her to have gross deformities and confined her to bed. These were initially ascribed to vitamin D deficiency. However, despite correction of the deficiency, she did not improve. A review of previous records already showed glucosuria in the absence of diabetes, but this finding was overlooked. Eight years into the disease, it was realised that the glucosuria despite normal blood sugar could also mean that the patient was losing other substances needed for proper bone formation. Further investigations showed hypophosphataemia, renal phosphate wasting, hypokalaemia, mild metabolic acidosis, alkaline urine pH, hypouricaemia and aminoaciduria, all compatible with a proximal renal tubular defect (Fanconi syndrome). The fragility fractures were due to poor bone mineralisation because of hypophosphataemia induced by the inability of the kidneys to conserve phosphorus.


Assuntos
Síndrome de Fanconi/complicações , Fraturas Ósseas/etiologia , Glicosúria/etiologia , Hipofosfatemia/etiologia , Túbulos Renais Proximais/anormalidades , Absorciometria de Fóton/métodos , Diagnóstico Diferencial , Síndrome de Fanconi/tratamento farmacológico , Síndrome de Fanconi/patologia , Síndrome de Fanconi/urina , Feminino , Fraturas Ósseas/diagnóstico por imagem , Fraturas Ósseas/tratamento farmacológico , Fraturas Ósseas/cirurgia , Humanos , Hipopotassemia/etiologia , Hipopotassemia/metabolismo , Hipofosfatemia/metabolismo , Túbulos Renais Proximais/metabolismo , Túbulos Renais Proximais/patologia , Pessoa de Meia-Idade , Fósforo/administração & dosagem , Fósforo/uso terapêutico , Resultado do Tratamento
7.
Pediatr Diabetes ; 19(1): 180-183, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-28493372

RESUMO

Fanconi-Bickel syndrome is a rare inherited disease characterized by the combination of hepatorenal glycogen accumulation, proximal renal tubular dysfunction and impaired utilization of glucose and galactose. The first symptoms of the disorder are recognized in late infancy as clinical characteristics appear. Therapeutic approach is mainly conservative with supplements of calcium, phosphate and vitamin D and small frequent feedings to avoid hypoglycemia. We report 1 clinical case of very early diagnosis, a 19 days old baby girl, in which the first clinical sign of the disease was the detection of glycosuria and vomits. Serum alkaline phosphatase levels were very high without rickets. The patient presented postprandial hyperglycemia and fasting hypoglycemia. A complete 24-hour glucose profile was obtained using a continuous glucose monitoring system in real time, which was fundamental not only for the diagnosis but also for the prevention of hypoglycemia. She received frequent small meals, galactose-free milk diet, and oral intakes of calcium, phosphorum, bicarbonate and vitamin D supplements with good evolution and normal height and weight gain.


Assuntos
Síndrome de Fanconi/diagnóstico , Síndrome de Fanconi/complicações , Síndrome de Fanconi/metabolismo , Feminino , Glicosúria/etiologia , Humanos , Hiperglicemia/etiologia , Recém-Nascido
8.
PLoS One ; 11(1): e0144640, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26741142

RESUMO

Pharmacological inhibition of the proximal tubular sodium-glucose linked cotransporter-2 (SGLT2) leads to glycosuria in both diabetic and non-diabetic settings. As a consequence of their ability to modulate tubuloglomerular feedback, SGLT2 inhibitors, like agents that block the renin-angiotensin system, reduce intraglomerular pressure and single nephron GFR, potentially affording renoprotection. To examine this further we administered the SGLT2 inhibitor, dapagliflozin, to 5/6 (subtotally) nephrectomised rats, a model of progressive chronic kidney disease (CKD) that like CKD in humans is characterised by single nephron hyperfiltration and intraglomerular hypertension and where angiotensin converting enzyme inhibitors and angiotensin receptor blockers are demonstrably beneficial. When compared with untreated rats, both sham surgery and 5/6 nephrectomised rats that had received dapagliflozin experienced substantial glycosuria. Nephrectomised rats developed hypertension, heavy proteinuria and declining GFR that was unaffected by the administration of dapagliflozin. Similarly, SGLT2 inhibition did not attenuate the extent of glomerulosclerosis, tubulointerstitial fibrosis or overexpression of the profibrotic cytokine, transforming growth factor-ß1 mRNA in the kidneys of 5/6 nephrectomised rats. While not precluding beneficial effects in the diabetic setting, these findings indicate that SGLT2 inhibition does not have renoprotective effects in this classical model of progressive non-diabetic CKD.


Assuntos
Compostos Benzidrílicos/farmacologia , Glucosídeos/farmacologia , Glicosúria/metabolismo , Hipertensão Renal/metabolismo , Hipoglicemiantes/farmacologia , Proteinúria/metabolismo , Insuficiência Renal Crônica/metabolismo , Inibidores do Transportador 2 de Sódio-Glicose , Animais , Modelos Animais de Doenças , Progressão da Doença , Fibrose , Expressão Gênica , Taxa de Filtração Glomerular , Glicosúria/tratamento farmacológico , Glicosúria/etiologia , Glicosúria/patologia , Humanos , Hipertensão Renal/tratamento farmacológico , Hipertensão Renal/etiologia , Hipertensão Renal/patologia , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Masculino , Nefrectomia/efeitos adversos , Proteinúria/tratamento farmacológico , Proteinúria/etiologia , Proteinúria/patologia , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Insuficiência Renal Crônica/tratamento farmacológico , Insuficiência Renal Crônica/etiologia , Insuficiência Renal Crônica/patologia , Transportador 2 de Glucose-Sódio/genética , Transportador 2 de Glucose-Sódio/metabolismo , Fator de Crescimento Transformador beta1/genética , Fator de Crescimento Transformador beta1/metabolismo , Falha de Tratamento
9.
Artigo em Inglês | MEDLINE | ID: mdl-25966748

RESUMO

Transient Fanconi syndrome without azotemia was diagnosed in a dog and was associated with ingestion of Chinese chicken jerky treats. Fanconi syndrome is a proximal renal tubular defect and a diagnosis was made based upon severe glucosuria with normoglycemia, and severe generalized aminoaciduria. The clinical signs of polyuria and polydipsia as well as the massive urinary metabolic abnormalities resolved after jerky treat withdrawal. While frequently seen in North America and Australia, this is the first report of jerky treat induced Fanconi syndrome in continental Europe. Clinicians should be aware of this potential intoxication and be vigilant for a history of jerky treat consumption in a dog with glucosuria.


Assuntos
Doenças do Cão/etiologia , Síndrome de Fanconi/veterinária , Alimentos em Conserva/intoxicação , Produtos da Carne/intoxicação , Animais , Doenças do Cão/diagnóstico , Doenças do Cão/terapia , Cães , Síndrome de Fanconi/diagnóstico , Síndrome de Fanconi/etiologia , Síndrome de Fanconi/terapia , Feminino , Glicosúria/diagnóstico , Glicosúria/etiologia , Glicosúria/veterinária
10.
Environ Health ; 13(1): 18, 2014 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-24629167

RESUMO

BACKGROUND: We aimed to investigate the mortality and causes of deaths of inhabitants with renal dysfunction induced by cadmium (Cd) exposure caused by heavy environmental contamination. METHODS: We conducted a 26-year follow-up survey targeting 7529 inhabitants of the Cd-polluted Jinzu River basin and 2149 controls from non-polluted areas who participated in urinary examinations for proteinuria and glucosuria conducted in 1979 to 1984. When the residents were divided into 4 groups, no finding group, glucosuria group, proteinuria group, glucoproteinuria group, mortality risk ratios for all and specific causes of these groups in the polluted area were compared with that of controls without glucosuria and/or proteinuria after adjustments for age at baseline, smoking status, and history of hypertension using Cox's proportional hazard model. RESULTS: The mortality risk ratios for all causes of proteinuria and glucoproteinuria in men and glucosuria, proteinuria, and glucoproteinuria in women of the polluted areas significantly increased compared with those of the controls with no urinary findings. Respiratory, renal, and cardiovascular diseases and diabetes in men, and all diseases except cerebrovascular diseases in women contributed toward an increased mortality of exposed glucoproteinuria groups, which involved chronic Cd toxicosis with renal tubular dysfunction. In women, the mortality risks for cancer of the colon and rectum, uterus and kidney and urinary tract were significantly higher in the exposed proteinuria and glucoproteinuria groups, suggesting associations between renal damage and cancer risk. In exposed women, the no finding group and glucoproteinuria group also showed increased mortality from ischemic heart diseases, indicating that all exposed women may be at risk for ischemic heart diseases. Although the control glucosuria and/or proteinuria group also showed high mortality for diabetes and renal diseases, the increased risk ratio for renal disease mortality was much higher in exposed subjects with urinary findings, particularly in women. CONCLUSIONS: These findings indicate that inhabitants with renal effects caused by Cd exposure had a poor life prognosis over long-term observation in both genders. Particularly in women, renal tubular dysfunction indicated by glucoproteinuria may increase mortality from cancer, ischemic heart diseases, and renal diseases.


Assuntos
Cádmio/toxicidade , Glicosúria/mortalidade , Nefropatias/induzido quimicamente , Nefropatias/mortalidade , Proteinúria/mortalidade , Poluentes Químicos da Água/toxicidade , Bronquite/mortalidade , Bronquite/urina , Cádmio/urina , Doenças Cardiovasculares/mortalidade , Doenças Cardiovasculares/urina , Causas de Morte , Diabetes Mellitus/mortalidade , Diabetes Mellitus/urina , Exposição Ambiental/efeitos adversos , Feminino , Seguimentos , Glicosúria/etiologia , Glicosúria/urina , Inquéritos Epidemiológicos , Humanos , Japão/epidemiologia , Nefropatias/urina , Masculino , Pessoa de Meia-Idade , Neoplasias/mortalidade , Neoplasias/urina , Razão de Chances , Pneumonia/mortalidade , Pneumonia/urina , Proteinúria/etiologia , Proteinúria/urina , Rios , Poluentes Químicos da Água/urina , Abastecimento de Água
11.
Iran J Kidney Dis ; 6(2): 99-104, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22388606

RESUMO

INTRODUCTION: The aim of this study was to test whether Nigella sativa (NS) seeds can reduce cisplatin-induced toxicity. MATERIALS AND METHODS: Thirty rats were divided into 3 groups to receive distilled water (control group), cisplatin (3 mg/kg per body weight for 3 days), and cisplatin and alcoholic extract of NS (100 mg/kg per body weight). Biochemical and histopathologic parameters were compared between the three groups on days 14 and 42 of the study. RESULTS: Blood urea nitrogen increased in the cisplatin and NS groups on days 14 and 42 compared to day 0 (P < .001). It was significantly in the cisplatin than in the control group on day 14 (P < .001). Serum creatinine had a similar profile in the cisplatin and NS groups as blood urea nitrogen. Serum triglyceride increased in the cisplatin and NS groups on day 14, but it decreased on day 42 (P < .05). Urine glucose concentration decreased in the cisplatin group on days 14 and 42 compared to day 0 (P < .001), and the same trend was seen in the NS group (P < .001). Histology of the kidneys exposed to cisplatin showed significant kidney injury, but the rats treated with NS showed a relatively well-preserved architecture. CONCLUSIONS: Cisplatin-induced nephrotoxicity was confirmed in our study. Nigella sativa seeds had nonsignificant effects on biochemical parameters, although the histopathologic properties of the kidneys relatively recovered after NS use.


Assuntos
Antineoplásicos/toxicidade , Cisplatino/toxicidade , Nefropatias/tratamento farmacológico , Nigella sativa , Fitoterapia/métodos , Extratos Vegetais/farmacologia , Animais , Creatinina/metabolismo , Etanol/farmacologia , Glicosúria/etiologia , Nefropatias/induzido quimicamente , Nefropatias/fisiopatologia , Masculino , Ratos , Sementes , Triglicerídeos/metabolismo
13.
Pol Merkur Lekarski ; 27(159): 232-5, 2009 Sep.
Artigo em Polonês | MEDLINE | ID: mdl-19827737

RESUMO

The case of 25 years old male patient with symptoms of hypertensive storm in the course of pheochromocytoma was presented. For some years he had been suffering from moderate increase in arterial blood pressure whose secondary cause was not suspected by physicians examining this patient. In presented case the course of pheochromocytoma has special characteristics, such as: clinical presentation in young age, the course alternate between periods of hypertension and phases of normal blood pressure, physical signs of Marfan's syndrome, increase of troponin level within hypertensive storm, and attributes of malignant hypertension presented as transient proteinuria and glycosuria within normoglycemia.


Assuntos
Neoplasias das Glândulas Suprarrenais/diagnóstico , Feocromocitoma/diagnóstico , Neoplasias das Glândulas Suprarrenais/sangue , Neoplasias das Glândulas Suprarrenais/complicações , Adulto , Glicosúria/etiologia , Humanos , Masculino , Feocromocitoma/sangue , Feocromocitoma/complicações , Proteinúria/etiologia , Troponina/metabolismo
14.
Biol Trace Elem Res ; 127(3): 257-68, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18979074

RESUMO

The aim of this study was to clarify whether consumption of cadmium (Cd)-polluted rice or Jinzu River water exerted any influence on the occurrence of renal tubular dysfunction and/or Itai-itai disease. From the participants of health examinations conducted in 1967 and 1968, 3,078 subjects who had resided for >30 years in the present hamlet and were aged >50 years were selected as the target population and were divided according to their residence in 55 hamlets. In a multiple regression analysis, the regression coefficients between rice-Cd concentration and prevalence of abnormal urinary findings (proteinuria, glucosuria, or proteinuria with glucosuria) or patients with Itai-itai disease were statistically significant between both sexes. The correlation between the prevalence of users of Jinzu River water and the occurrence of glucosuria in men as well as abnormal urinary findings in women was not statistically significant. We surmise that eating Cd-polluted rice and drinking and/or cooking with Jinzu River water influenced the occurrence of Itai-itai disease. The occurrence of renal tubular dysfunction is likely to have also been influenced by both factors, with eating Cd-polluted rice having a greater impact on the occurrence of renal tubular dysfunction as compared to drinking and/or cooking with Jinzu River water.


Assuntos
Intoxicação por Cádmio/epidemiologia , Cádmio/análise , Nefropatias/epidemiologia , Oryza/química , Poluentes Químicos da Água/toxicidade , Adulto , Idoso , Idoso de 80 Anos ou mais , Cádmio/toxicidade , Feminino , Contaminação de Alimentos , Glicosúria/etiologia , Glicosúria/metabolismo , Humanos , Japão , Nefropatias/etiologia , Nefropatias/metabolismo , Masculino , Pessoa de Meia-Idade , Prevalência , Proteinúria/etiologia , Proteinúria/metabolismo
16.
World J Pediatr ; 4(2): 102-5, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18661763

RESUMO

BACKGROUND: Since the diverse manifestations of renal impairment appear in different periods of Wilson's disease, misdiagnosis or missed diagnosis is not rare. This study was undertaken to find the clinical features of renal impairment in children with Wilson's disease or hepatolenticular degeneration (HLD). METHODS: Eighty-five children with HLD who had been treated at our department between January 1991 and June 2006 were retrospectively studied. The clinical data of 25 patients with renal impairment were analyzed. RESULTS: In the 85 HLD patients, 34 had renal impairment. Nine of the 34 patients with D-penicillamine treatment were excluded. In the remaining 25 patients, 7 had initiated symptoms of renal impairment, 5 of them with edema, 1 with gross hematuria, and 1 with acute hemolysis and acute renal failure. Twelve of the 25 patients had proteinuria, 14 had hematuria, and 5 had both proteinuria and hematuria. Urine glucose was positive in 4 patients, urine N-acetyl-beta-D-glucosaminidase (NAG) increased in 5, and urine beta2-microglobulin increased in 6. Urine red blood cell (RBC) phase was detected in 7 patients, including glomerular hematuria in 5 patients and non-glomerular hematuria in 2. Blood urea nitrogen and creatinine increased in 1 patient. B-ultrasound revealed bilaterally enlarged kidneys in 3 patients. Kidney biopsy showed diffuse mesangial proliferation and IgA deposit in mesangial region in 1 patient. All of the 25 patients had cornea K-F ring and the level of ceruloplasmin decreased. Six patients had a family history of HLD. CONCLUSIONS: The manifestations of renal impairment with HLD are varied. HLD should be excluded from patients with unexplained renal impairment, while those with HLD should take examinations of the kidney to identify renal impairment. We propose that renal function and urinalysis should be checked regularly in patients receiving treatment of D-penicillamine.


Assuntos
Degeneração Hepatolenticular/complicações , Degeneração Hepatolenticular/fisiopatologia , Insuficiência Renal/diagnóstico , Insuficiência Renal/fisiopatologia , Acetilglucosaminidase/urina , Acidose Tubular Renal/etiologia , Adolescente , Ceruloplasmina/metabolismo , Quelantes/uso terapêutico , Criança , Feminino , Glicosúria/etiologia , Hematúria/etiologia , Degeneração Hepatolenticular/tratamento farmacológico , Humanos , Testes de Função Renal , Masculino , Penicilamina/uso terapêutico , Proteinúria/etiologia , Insuficiência Renal/etiologia , Estudos Retrospectivos , Urinálise
18.
J Pediatr Endocrinol Metab ; 17(11): 1565-9, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15570995

RESUMO

Latent autoimmune diabetes mellitus in adults (LADA) is characterized by clinical presentation as type 2 diabetes mellitus after 25 years of age, initial control achieved with oral hypoglycemic agents for at least 6 months, presence of autoantibodies and some immunogenetic features of type 1 diabetes mellitus. An 8.3 year-old girl was referred to our pediatric endocrinology department because of incidental glucosuria. She did not complain of polyuria, polydipsia, or weight loss. Her body mass index (BMI) was at the 80th percentile. Fasting glucose was 126 mg/dl, and OGTT glucose level at 120 min was 307 mg/dl. Although C-peptide levels were normal, her first phase insulin response (FIR) was lower than the 1st percentile. Anti-insulin antibody (AIA), islet cell antibody (ICA), and anti-glutamic acid decarboxylase (antiGAD) were negative. According to the clinical and laboratory findings, she was diagnosed as having type 2 diabetes mellitus. She was started with oral anti-diabetic treatment for a period of 1 year. Insulin had to be initiated for worsening of HbA1c levels. In the fourth year of follow-up, she was admitted to our hospital with diabetic ketoacidosis although she was on an intensive insulin regimen. At this time, C-peptide levels were low, antiGAD and AIA were positive with HLA DR3/DQ2 haplotype. In addition, her thyroid peroxidase antibody and endomysium antibody were found to be high at follow-up. Small intestinal biopsy revealed celiac disease. This patient may represent the first case of latent autoimmune diabetes mellitus in children (LADC) with autoimmune thyroiditis and celiac disease.


Assuntos
Doença Celíaca/complicações , Diabetes Mellitus Tipo 1/etiologia , Tireoidite Autoimune/complicações , Glicemia/metabolismo , Índice de Massa Corporal , Peptídeo C/metabolismo , Criança , Diabetes Mellitus Tipo 1/sangue , Feminino , Glicosúria/etiologia , Humanos , Hipoglicemiantes/uso terapêutico , Insulina/uso terapêutico
20.
Eur J Clin Nutr ; 58(4): 615-20, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15042129

RESUMO

OBJECTIVE: To assess the association between soyfood intake and risk of glycosuria. DESIGN AND METHODS: A cross-sectional study was conducted among participants of the Shanghai Women's Health Study, a population-based cohort study of women aged 40-70 y. Information on usual intake of soyfoods was obtained at baseline survey through an in-person interview using a validated food-frequency questionnaire. Included in this study were 39,385 cohort members screened for diabetes at the baseline survey and free of previously diagnosed diabetes, cardiovascular diseases, kidney diseases, and cancer. There were 323 women who tested positive for urine glucose. Odds ratios (ORs) and 95% confidence intervals (CIs) were employed to measure the association between soyfood intake and glycosuria using unconditional logistic regression. SETTING: Urban communities of Shanghai, China. RESULTS: Overall, soyfood intake was not related to the risk of glycosuria. Among postmenopausal women, however, intake of tofu and other soy products was inversely associated with risk of glycosuria after adjustment for potential confounders. The ORs across quintiles of intake were 1.0, 0.75 (95% CI=0.47-1.20), 0.79 (95% CI=0.51-1.25), 0.53 (95% CI=0.32-0.88), and 0.51 (95% CI=0.26-0.98; P for trend=0.05). Further analyses showed that the inverse association was primarily confined to postmenopausal women with a body mass index (BMI) of <25 kg/m2. The adjusted OR comparing the extreme quintiles was 0.36 (95% CI=0.13-0.97; P for trend=0.004). CONCLUSIONS: Soyfoods may play a role in the development of glycosuria, an important indicator of diabetes, among postmenopausal women with a low BMI.


Assuntos
Glicosúria/etiologia , Alimentos de Soja/efeitos adversos , Saúde da Mulher , Adulto , Idoso , Índice de Massa Corporal , China , Estudos Transversais , Diabetes Mellitus Tipo 2/etiologia , Inquéritos sobre Dietas , Ingestão de Energia , Feminino , Humanos , Pessoa de Meia-Idade , Fatores de Risco , Inquéritos e Questionários , População Urbana
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA